+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Living Cell Technologies Limited - logo

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore function in New Zealand. Its lead product is NTCELL, an alginate coated capsule, which is in Phase IIb clinical trial for the treatment of Parkinson's disease. In addition to this, NTCELL has the potential to be used in a number of other central nervous system indications, including Huntington's and Alzheimer's. The company was founded in 1987 and is based in Auckland, New Zealand.

From
From
Neuropathic Pain - Pipeline Review, H2 2019 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 838 pages
From
From
Calcitonin Gene Related Peptide - Pipeline Review, H2 2020 - Product Thumbnail Image

Calcitonin Gene Related Peptide - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 96 pages
From
Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H2 2019 - Product Thumbnail Image

Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 81 pages
From
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 pages
From
Huntington Disease - Pipeline Review, H1 2020 - Product Thumbnail Image

Huntington Disease - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 390 pages
From
From
From
From
From
Obesity - Pipeline Review, H2 2020 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 640 pages
From
From
Regenerative Medicine Market in the US 2017-2021 - Product Thumbnail Image

Regenerative Medicine Market in the US 2017-2021

  • Report
  • July 2017
  • 107 pages
From
Loading Indicator
adroll